STAT

As calls mount to ban embryo editing with CRISPR, families hit by inherited diseases say, not so fast

Prominent #CRISPR experts are calling for a global moratorium on embryo editing, but families plagued by severe inherited diseases argue they should have this option if it's safe.

Neena Nizar’s earliest memory is of her father tying her to an ironing board. His beloved toddler, who seemed fine when she was born, had something very, very wrong with her: Neena’s bones bent and curved and she wasn’t growing normally, so his engineer’s mind desperately seized on the ironing-board solution.

But the problem — which some doctors diagnosed as polio and others as rickets or “we have no idea” — was even worse than bones that wouldn’t stay straight. They also broke down faster than they grew, with weak cartilage where strong bone should be. By the time other little girls were skipping and running and kicking balls, she was in pain and could barely get around. “I had to be carried into school, and I had rods in my hips and metal clamps to hold my bones in place,” said Nizar, who was born in Dubai. “Growing up, that was beyond hard. It was horrible.”

So when Nizar, now 41 and living in Nebraska, hears scientists’ emphatic calls to prohibit “embryo editing” of disease-causing genes, her reaction is shaped by decades of her own suffering — compounded by that of the two sons who inherited her devastating mutation.

“It’s easy to get on your high

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks